Evidence map›Paper›PMID 24121402›Full record

ArticleThe Journal of investigative dermatology2014

Crosstalk between keratinocytes and T cells in a 3D microenvironment: a model to study inflammatory skin diseases.

Ellen H van den Bogaard, Geuranne S Tjabringa, Irma Joosten, Mieke Vonk-Bergers, Esther van Rijssen, Henk J Tijssen, Mirthe Erkens, Joost Schalkwijk, Hans J P M Koenen

Abstract read
PubMed Publisher
In one paragraph

Article in The Journal of investigative dermatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 159 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. CD4Frontiers in immunology · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Toward the Next Generation of In Silico Modeling of Dynamic Host-Microbiota Interactions in the Skin.JID innovations : skin science from molecules to population health · 2025
    Review
  9. Article
  10. Article
  11. Enhancing Transcutaneous Drug Delivery: Advanced Perspectives on Skin Models.JID innovations : skin science from molecules to population health · 2025
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Diversity of human skin three-dimensional organotypic cultures.Current opinion in genetics & development · 2024
    Review
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ellen H van den BogaardDepartment of Dermatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Geuranne S TjabringaDepartment of Dermatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Irma JoostenDepartment of Laboratory Medicine, Laboratory of Medical Immunology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Mieke Vonk-BergersDepartment of Dermatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Esther van RijssenDepartment of Laboratory Medicine, Laboratory of Medical Immunology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Henk J TijssenDepartment of Laboratory Medicine, Laboratory of Medical Immunology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Mirthe ErkensDepartment of Dermatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Joost SchalkwijkDepartment of Dermatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: j.schalkwijk@derma.umcn.nl.
Hans J P M KoenenDepartment of Laboratory Medicine, Laboratory of Medical Immunology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: h.koenen@labgk.umcn.nl.
Radboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interaction between keratinocytes and immune cells plays a major role in the development of inflammatory skin diseases like psoriasis and atopic dermatitis. Pharmacological intervention to inhibit T cell-derived proinflammatory mediators is an effective therapy in the treatment of psoriasis. Here, we present a model to study the interaction between keratinocytes and T cells in a three-dimensional (3D) microenvironment, based on human skin equivalents populated with CD4+ T cells. T cell migration into the dermis initiated keratinocyte activation within 2 days, with hallmarks of a psoriasiform inflammation after 4 days. Expression of epidermal psoriasis marker genes was upregulated, and proinflammatory cytokines and chemokines were highly expressed. Disturbed epidermal differentiation was shown by downregulated filaggrin expression and involucrin expression in the spinous layer. These effects were mediated via soluble factors produced by the T cells. The psoriasiform inflammation was also observed using T helper type 1 (Th1)- and Th17-polarized CD4+ T cells. We validated our model by treatment with anti-inflammatory drugs that reduced the expression of proinflammatory cytokines and chemokines and suppressed the psoriasiform inflammation. We propose that our T cell-driven inflammatory skin equivalent model has potential to study the pathogenesis of inflammatory skin diseases and may serve as a preclinical screening tool for anti-inflammatory drugs.

Indexed as

Anti-Inflammatory AgentsCD4-Positive T-LymphocytesCell CommunicationCell Culture TechniquesCell MovementDermatitis, AtopicDermisFilaggrin ProteinsHumansKeratinocytesLymphocyte ActivationPrimary Cell CulturePsoriasisReceptor Cross-TalkTh17 CellsTh1 CellsAnti-Inflammatory AgentsFilaggrin ProteinsFLG protein, human

Identifiers

PMID24121402
OpenAlexW2111037069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.